TrialDiabetes care2015

Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.

Julio Rosenstock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.